(Press-News.org) An analysis of data from 10 studies indicates that the presence of low frequency (also called "minority") human immunodeficiency virus type 1 (HIV-1) drug resistance mutations, particularly those involving nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance, are significantly associated with an increased risk of first-line antiretroviral treatment failure, according to an article in the April 6 issue of JAMA.
Using traditional tests, the prevalence of transmitted drug resistance mutations is estimated to be between 8 percent and 16 percent among HIV-1 infected persons in North America and Europe. These tests may fail to detect the presence of low-frequency, or minority, drug resistance mutations, according to background information in the article. "Presence of these minority variants may adversely affect the response to antiretroviral treatment (ART), but their clinical significance continues to be the subject of considerable debate and uncertainty," the authors write.
Jonathan Z. Li, M.D., of Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues conducted a systematic review and pooled analysis to examine the relationship between the presence of baseline low-frequency HIV-1 drug resistance mutations and the risk of virologic failure with NNRTI-based regimens in treatment-naive (had not previously received treatment) adults. The authors identified 10 studies that met criteria for the primary analysis, which included data for 985 participants.
Low-frequency drug resistance mutations were detected in 187 participants, including 117 of 808 patients in the cohort studies. The researchers found that low-frequency HIV-1 drug resistance mutations were associated with a 2.3 times increased risk of virologic failure after controlling for medication adherence, race/ethnicity, baseline CD4 cell count, and plasma HIV-1 RNA levels. The increased risk of virologic failure was most strongly associated with NNRTI-resistant minority variants (2.6 times increased risk).
"Among participants from the cohort studies, 35 percent of those with detectable minority variants experienced virologic failure compared with 15 percent of those without minority variants. The presence of minority variants was associated with 2.5 to 3 times the risk of virologic failure at either 95 percent or greater or less than 95 percent overall medication adherence. A dose-dependent increased risk of virologic failure was found in participants with a higher proportion or quantity of drug-resistant variants," the researchers write.
Analysis indicated that the presence of a drug-resistant minority variant, overall medication adherence, and race/ethnicity were all significant independent predictors of virologic failure. Compared with white participants, those of black, Hispanic, and other races/ethnicities all had an increased risk of virologic failure. "The relationship between race/ethnicity and virologic failure may be mediated by factors such as socioeconomic status, drug and alcohol use, or other factors not accounted for here that may correlate with adherence and could contribute to residual confounding," the authors write.
The researchers add that using the most sensitive test for NNRTI resistance mutations, approximately 11 patients would need to be screened prior to initiating an NNRTI based ART regimen to avoid 1 case of virologic failure.
"These data provide a rationale for developing standardized clinical assays for the detection of NNRTI-resistant minority variants. Because NNRTI-based regimens are the most commonly prescribed first-line antiretroviral therapy, the clinical use of ultrasensitive screening for drug-resistant HIV could help identify individuals at greatest risk of virologic failure and allow ART to be tailored appropriately."
###
(JAMA. 2011;305[13]1327-1335. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
To contact corresponding authors Jonathan Z. Li, M.D., or Daniel R. Kuritzkes, M.D., call Lori Shanks at 617-534-1604 or email ljshanks@partners.org.
For More Information: Contact the JAMA/Archives Media Relations Department at 312-464-JAMA or email: mediarelations@jama-archives.org.
HIV-1 drug resistance mutations associated with increased risk of antiretroviral treatment failure
2011-04-06
ELSE PRESS RELEASES FROM THIS DATE:
Death rates after hospitalization down for oldest heart failure patients
2011-04-06
Death rates after hospitalization for heart failure have dropped for veterans age 80 and older, but rehospitalizations remain frequent, according to a study in the American Heart Association journal Circulation: Heart Failure.
Results of the study highlight a need to better identify which patients among the oldest are more likely to be rehospitalized not just for heart failure, but for any reason, said Rashmee Shah, M.D., lead author of the study and postdoctoral fellow in the Department of Health Research and Policy at Stanford University School of Medicine in Palo Alto, ...
AIT Becomes the First Software Vendor in American Translators Association's Member-Provider Program
2011-04-06
Advanced International Translations (AIT), a leading supplier of translation management software for agencies and freelancers, became the first member-provider software company in the American Translators Association (ATA).
ATA's Member-Provider Program was established to provide support to members in their practice of translation and interpreting. Vendors in the program are selected after careful review of the company's products, services, reliability, and value. The selection process includes feedback and recommendations from ATA members about the vendor and its products.
Participation ...
Off-label marketing of medicines in the US is rife but difficult to control
2011-04-06
Despite Federal Drug Administration regulation of the approval and use of pharmaceutical products, "off-label" marketing of drugs (for purposes other than those for which the drug was approved) has occurred in all aspects of the US health care system. In a study published in this week's PLoS Medicine, Aaron S. Kesselheim from Brigham and Women's Hospital, Boston, USA and colleagues report that the most common alleged off-label marketing practices also appear to be the most difficult to control through external regulatory approaches. They identified three main goals of alleged ...
Comprehensive approach can improve clinical care of Kenyan children
2011-04-06
A multifaceted approach that addressed deficiencies in clinical knowledge, skills, motivation, resources, and the organization of care was associated with improvements in practice for high mortality conditions in young children in rural Kenya compared with less comprehensive approaches.
This finding from a novel study by Philip Ayieko from the KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya, and colleagues, published in this week's PLoS Medicine, is important as it suggests that specific efforts are needed to improve pediatric care in rural areas of poor countries ...
Effects of pneumococcal vaccination program on pneumococcal carriage and invasive disease
2011-04-06
Using a cross-sectional study, Stefan Flasche and colleagues investigated the effects of the UK pneumococcal vaccination program on serotype-specific carriage and invasive pneumococcal disease.
There are more than 90 Streptococcus pneumoniae serotypes that can cause invasive pneumococcal disease (IPD). The pneumococcal conjugate vaccine PCV7 contains antigens from seven serotypes responsible for IPD. Immunization with PCV7 prevents both IPD disease and carriage of these seven serotypes, but after vaccination non-vaccine serotypes could colonize the nasopharynx. There ...
Ben Cohen: The Problem Solver for Company Energy Bill Expenditures
2011-04-06
For companies facing the ongoing challenge of energy related costs a New York based entrepreneur is offering instant lower pricing options via his Energy Deregulation Business Model. "The breakup of Ma Bell offered consumers the opportunity to shop for lower phone rates and that same situation is now available for energy consumers currently in the states of Texas, Connecticut, New Jersey, New York as well as parts of Pennsylvania and Illinois," said Ben Cohen.
Cohen's business solution (www.cohenenergysolutions.emexpower.com) allows clients to lock in on fixed rates ...
Sandia researchers merge gaming, simulation tools to create models for border security
2011-04-06
VIDEO:
Developed via funding from the Department of Homeland Security's Customs and Border Protection (CBP), the Borders High Level Model is a high-fidelity simulation and analysis program that aids policy and...
Click here for more information.
LIVERMORE, Calif. —With funding from the Department of Homeland Security's Customs and Border Protection (CBP), researchers at Sandia National Laboratories have developed a high-fidelity simulation and analysis program that aids ...
Einstein HR Announces New Offices To Meet High Demand For Outsourced HR Solutions
2011-04-06
Company founder and CEO Layne Davlin today announced that EinsteinHR has inaugurated new offices which will allow the company to better serve its expanded client-base. A dramatic increase in demand for outsourced HR solutions necessitated the move.
"EinsteinHR is strategically positioned for growing with existing accounts and acquiring new customers with a limited ramp-up time," says Layne Davlin.
Top-tier small- and medium-sized businesses rely on EinsteinHR in outsourcing everything from payroll and paying employment related taxes, to risk management, providing ...
NYU Langone Medical Center cardiologists present at ACC 60th Annual Scientific Session
2011-04-06
Cardiologists from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research findings at the American College of Cardiology 60th Annual Scientific Session held April 2-5, 2011 in New Orleans, Louisiana. Significant research findings presented by NYU Langone cardiologists included:
The Relationship between Bleeding and Mortality in Patients on Dual Antiplatelet Therapy vs. Aspirin Alone: Results from the CHARISMA Trial
Author: Jeffrey S. Berger, MD, MS, FACC, assistant professor, Medicine and director of Cardiovascular Thrombosis
Little is ...
From Afghanistan, Djibouti and Saudi Arabia to The Las Vegas Strip, Comedian Don Barnhart Brings Laughter Nightly In His Own Show At The Clarion Hotel
2011-04-06
The Clarion Hotel is located at 305 Convention Center Dr. (In the shadow of the WYNN Hotel) with plenty of free parking! Tickets are $29.95 making it one of the best bargains in Las Vegas. Unlike other comedy venues on the strip, Barnhart's showroom serves a full dinner and bar menu, bottle service and VIP Booths. Show information, reservations or group sales: 702-466-4121
An award-winning comedian, writer, director and actor Barnhart received the Bob Hope Award in 2010 for his continued service entertaining the troops stationed overseas and in 2007 he won the Grand ...